Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Several states are trying to reduce healthcare costs by importing medicine from countries where it costs less, but this is a deeply flawed policy proposal.

Pharmacy Benefit Managers' under-reimbursements make pharmacies perfect targets for counterfeiters—and make the U.S. drug supply less safe as a result.

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

October 15, 2024: FDA issues new DSCSA guidance

October 16, 2024

The FDA granted exemptions for certain trading partners and small dispensers to avoid supply chain disruptions. Stories from the week in counterfeit medicine news.

PSM Advocates for SHOP SAFE legislation at Anti-Counterfeiting Day on the Hill

October 8, 2024

Our Executive Director, Shabbir Safdar, along with PSM members, shared examples of pharmaceutical counterfeits and helped attendees understand why current systems for stopping counterfeit product sales do not work well.

October 7, 2024: DEA warning – Dozens of fake online pharmacies sold millions of fake pills to customers in all 50 states

October 7, 2024

An indictment by the Department of Justice against 18 individuals who allegedly sold counterfeit pills via dozens of fake pharmacy websites to residents in all 50 states prompts warnings from two additional federal agencies.

September 30, 2024: 27 individuals indicted in Puerto Rico over wholesale distribution of misbranded and diverted medicine

September 30, 2024

Twenty-seven people in Puerto Rico indicted in misbranded and diverted drug case, CBP seized counterfeit and misbranded drugs in two states, and fake arthritis and cancer medications seized in India.

PSM Compounded Weight Loss Drugs Poll

September 26, 2024

PSM commissioned a survey about compounded diabetes and weight loss injectable drugs. 1,000 likely voters across political affiliations were crystal clear — they are worried about safety and the current lack of oversight. See the full results.

September 23, 2024: Administrative complaint filed alleging insulin price inflation by pharmacy benefit managers

September 23, 2024

The Federal Trade Commission issued an administrative complaint against the three largest pharmacy benefit managers, alleging that the companies used their market power to inflate the cost of insulin for U.S. patients.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

Fake Ozempic is being sold at Mexican border pharmacies. Learn more.

youtube-video-thumbnail

How did counterfeit Botox turn into a full-blown public health emergency? Watch

Injunctions, expensive settlements, and jail aren't stopping black market HIV drug schemes. Watch.

Click the images below to see more recent videos.